Breast cancer survival

Adjuvant Ribociclib and Endocrine Therapy in Patients with HR+/HER2 Negative Early Breast Cancer: Phase III NATALEE Trial

By Dr. Shipra Gandhi from Roswell Park Comprehensive Cancer Center   Findings from the MonarchE clinical trial1 led to the…

1 year ago

DESTINY-Breast04 Trial

By Paolo Tarantino, MD Dana-Farber Cancer Institute/Harvard Medical School   "Overall, a major shift in the way we treat breast…

2 years ago